AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Solana Co Director's Dealing 2019

Apr 1, 2019

32724_dirs_2019-04-01_6e00d9b8-0647-4e3c-9dbc-72f10d0e31ea.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT)
CIK: 0001610853
Period of Report: 2019-03-28

Reporting Person: STRAW EDWARD M (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-03-28	Stock Option (Right to Buy)	$6.76	A	16218	Acquired	2029-03-28	Class A Common Stock (16218)	Direct

Footnotes

F1: Grant to the Reporting Person of a stock option under the Issuer's 2018 Omnibus Incentive Plan. The shares vest in a series of twelve (12) successive equal monthly installments measured from March 28, 2019, subject to the Reporting Person's continued service through each applicable vesting date.